Scientists around the world are campaigning in favor of sensible regulation of stem-cell therapies. The recent conference of the International Society for Stem Cell Research (ISSCR) opened with a panel discussion about how to sort the real from the bogus treatments.
Coffman is one of the most vulnerable incumbents in the U.S. Congress, and reporters should be watching for him to make statements and stage events, like this stem-cell tour, that may appeal to moderate voters but run counter to Coffman's forever-held beliefs and policy positions.
One of the more memorable ads this election is the House Majority PAC's attack on Coffman for opposing embryonic stem cell research. In its Truth Test on this topic, 9News should have said more about the ramifications of Coffman's position.
Linked up with the others, Coffman and Coors could do considerable damage to medical research, women's rights, and the dreams of family for childless couples. Fortunately, democracy provides us a remedy. Remember in November!
Romney has an opportunity to break with the more extreme elements of his party on an issue that has consistently shown to be important to the American people, and one that he supported for a time as governor: federal embryonic stem cell research.
Both Newt Gingrich and Mitt Romney supported embryonic stem cell research in the past. Both men, attempting to gain political advancement, have flip-flopped on the issue. But there is an important difference between the two men.